Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres.

Chiara TaniElena ElefanteMiguel Martin-CascónMeriem BelhocineCristina Lavilla OllerosRoberta VagelliChiara StagnaroNathalie Costedoat-ChalumeauGuillermo Ruiz-IrastorzaMarta Mosca

Published in: Lupus science & medicine (2018)

Despite the limitation due to the small number of patients and the uncontrolled nature of the study, these data show that TAC can be considered a valid therapeutic option in patients with SLE, especially for renal involvement.

Keyphrases

systemic lupus erythematosus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
machine learning
deep learning
artificial intelligence